ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
벨 마비 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에 CAGR은 5.0%를 나타낼 것으로 예측되고 32억 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 벨 마비에 대한 인식 제고, 보험급여 정책 발전, 면역력 저하로 인한 바이러스 감염 유병률 증가, 건강하지 않은 생활 방식 확산, 주요 의약품사의 높은 관심 등에 기인할 수 있습니다. 예측 기간의 주요 동향에는 연구개발 투자, 비침습적 치료 및 신기술 개발, 귀·눈 감염 유병률 증가, 대중의 질병 인식 제고, 적절한 벨 마비 치료를 위한 승인 의약품 부족 등이 포함됩니다.
향후 5년간 5.0% 성장 전망은 이전 예측 대비 0.1% 소폭 하락한 수치입니다. 이 하락은 주로 미국과 타국 간 관세 영향 때문입니다. 관세 장벽은 스페인 및 한국산 코르티코스테로이드 제제와 안면 신경근 자극기의 공급원 비용 증가로 미국 신경과 치료를 저해할 것으로 예상되며, 이로 인해 안면 마비 회복이 지연되고 신경과 진료 비용이 상승할 것입니다. 또한 상호 보복 관세와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 효과가 더 광범위하게 될 것입니다.
바이러스 감염의 증가하는 유병률은 벨 마비 치료 시장 성장을 촉진할 것으로 예상됩니다. 생체 세포를 침입해 증식하는 바이러스로 인한 감염은 바이러스 확산 및 변이를 촉진하는 전 세계 여행, 도시화, 기후 변화 등의 요인으로 인해 더욱 흔해지고 있습니다. 벨 마비 치료에는 염증 감축을 위한 코르티코스테로이드와 바이러스 감염이 의심될 경우 아시클로버 또는 발라시클로버 같은 항바이러스제가 포함되며, 이는 안면 근육 기능 개선과 회복을 목표로 합니다. 예를 들어, 2023년 11월, 미국 질병 예방관리센터는 2021-2022년 인플루엔자 시즌 동안 인플루엔자 감염자 수가 900만명, 인플루엔자와 관련된 진료자 수가 400만명, 인플루엔자에 관련된 입원자 수가 10만명, 인플루엔자에 의한 사망이 발생했다고 보고했습니다. 이러한 바이러스 감염의 증가하는 유병률은 벨 마비 치료 시장 확장에 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 벨 마비 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 벨 마비 치료 시장 : 성장률 분석
세계의 벨 마비 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 벨 마비 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 벨 마비 치료 : 총 잠재시장 규모(TAM)
제6장 시장 세분화
세계의 벨 마비 치료 시장 : 진단별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
자기 공명 영상법(MRI)
컴퓨터 단층 촬영(CT) 스캔
근전도 검사
세계의 벨 마비 치료 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
약물치료
물리치료
수술
세계의 벨 마비 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
세계의 벨 마비 치료 시장, 자기 공명 영상법(MRI) 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
다른 원인 배제를 위한 뇌 MRI
안면 신경 평가를 위한 조영 MRI
신경경로 기능적 MRI
세계의 벨 마비 치료 시장, 컴퓨터 단층 촬영(CT) 스캔 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
두개골과 안면골 평가를 위한 CT 스캔
염증 검출을 위한 조영 CT
신경 손상 평가를 위한 고해상도 CT
세계의 벨 마비 치료 시장, 근전도 검사(EMG) 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
안면 신경 전도 검사를 위한 근전도
신경 전도 속도(NCV) 검사
신경 손상의 중증도를 평가를 위한 근전도 검사
제7장 지역별 및 국가별 분석
세계의 벨 마비 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 벨 마비 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
벨 마비 치료 시장 : 경쟁 구도
벨 마비 치료 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Sanofi SA
Bristol-Myers Squibb and Company
AstraZeneca
Abbott Laboratories
Novartis AG
GlaxoSmithKline PLC
Roche Holding AG
Takeda Pharmaceutical Company Limited
Eli Lily and Company
Gilead Sciences Inc.
Siemens Healthcare GmbH
Teva Pharmaceutical Industries Ltd.
Regeneron Pharmaceuticals Inc.
Biogen Inc.
Astellas Pharma Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
벨 마비 치료 시장(2029년) : 새로운 기회를 제공하는 국가
벨 마비 치료 시장(2029년) : 새로운 기회를 제공하는 부문
벨 마비 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Bell's Palsy treatment encompasses medical and therapeutic approaches designed to manage and alleviate the symptoms of Bell's Palsy, which is characterized by sudden, temporary weakness or paralysis of the facial muscles on one side of the face. The goal of treatment is to reduce inflammation, alleviate pain, protect the eye, and improve muscle function, often involving medications and supportive care.
The primary diagnostic methods for Bell's Palsy include magnetic resonance imaging (MRI), computed tomography (CT) scans, and electromyography. MRI is a non-invasive imaging technique that utilizes powerful magnets and radio waves to create detailed images of internal structures. Treatment options consist of medication, physical therapy, and, in some cases, surgery. These treatments are typically administered in hospitals and specialty clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The bell's palsy treatment market research report is one of a series of new reports from The Business Research Company that provides bell's palsy treatment market statistics, including bell's palsy treatment industry global market size, regional shares, competitors with a bell's palsy treatment market share, detailed bell's palsy treatment market segments, market trends and opportunities, and any further data you may need to thrive in the bell's palsy treatment industry. This bell's palsy treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bell's palsy treatment market size has grown strongly in recent years. It will grow from $2.5 billion in 2024 to $2.63 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to the increasing demand for minimally invasive procedures, rising government support, rising demand for technologically advanced treatments, increasing awareness about the health and availability of new treatments, and increasing prevalence of ear and eye infections.
The bell's palsy treatment market size is expected to see strong growth in the next few years. It will grow to $3.2 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing awareness of bell's palsy, advancements in reimbursement policies, increasing prevalence of viral infection due to poor immunity, rising unhealthy lifestyle, and high focus of leading pharmaceutical companies. Major trends in the forecast period include investment in research and development, the development of less invasive and new technologies for treatment, increasing prevalence of ear and eye infections, growing awareness among the population, the disease, and lack of approved drugs for the appropriate bell's palsy treatment.
The forecast of 5.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. neurological care by increasing the cost of corticosteroid formulations and facial neuromuscular stimulators sourced from Spain and South Korea, thereby delaying recovery from facial paralysis and elevating neurology clinic expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of viral infections is anticipated to drive growth in the bell's palsy treatment market. Viral infections, caused by viruses that invade living cells to reproduce, are becoming more common due to factors such as global travel, urbanization, and climate change, which aid in the spread and mutation of viruses. Bell's palsy treatment often includes corticosteroids to reduce inflammation and antiviral medications such as acyclovir or valacyclovir when a viral cause is suspected, with the goal of improving facial muscle function and recovery. For example, in November 2023, the Centers for Disease Control and Prevention reported that during the 2021-2022 flu season, there were 9 million flu cases, 4 million flu-related medical visits, 100,000 flu-related hospitalizations, and 5,000 flu deaths. This growing prevalence of viral infections is contributing to the expansion of the bell's palsy treatment market.
Key players in the bell's palsy treatment market are focusing on establishing facial palsy care centers to offer integrated care, improve patient outcomes, and streamline treatment processes. A facial palsy care center is a specialized facility dedicated to diagnosing, treating, and rehabilitating individuals with facial paralysis. For instance, in July 2023, Sakra World Hospital, a multi-specialty hospital based in India, opened a Comprehensive Facial Palsy Care Center to provide specialized treatment for facial paralysis. The center employs a multidisciplinary approach, involving neurologists, plastic surgeons, physiotherapists, and speech therapists, to manage various types of facial paralysis, including Bell's palsy, congenital facial palsy, and facial nerve injuries.
In October 2023, Amgen Inc., a US-based biotechnology company focused on discovering, developing, manufacturing, and marketing medicines for serious illnesses, acquired Horizon Therapeutics plc for $27.8 billion. This acquisition is aimed at strengthening Amgen's portfolio in rare diseases, driving revenue growth, and leveraging its existing expertise to create innovative therapies that address unmet medical needs. Horizon Therapeutics plc is an Ireland-based biotechnology company specializing in the development of treatments for rare and autoimmune diseases.
Major companies operating in the bell's palsy treatment market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb and Company, AstraZeneca, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Takeda Pharmaceutical Company Limited, Eli Lily and Company, Gilead Sciences Inc., Siemens Healthcare GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Aurobindo Pharma, Cipla Inc., Lupin Limited, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited
North America was the largest region in the bell's palsy treatment market in 2024. The regions covered in the bell's palsy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bell's palsy treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bell's palsy treatment market consists of revenues earned by entities by providing services such as facial exercises, massage therapy, and counseling services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bell's palsy treatment market also includes sales of prednisone, acyclovir, valacyclovir, and eye ointments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bell's Palsy Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bell's palsy treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bell's palsy treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bell's palsy treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Diagnosis: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Electromyography
2) By Treatment: Medication; Physical Therapy; Surgery
3) By End-User: Hospital; Specialty Clinics
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Brain MRI To Rule Out Other Causes; MRI With Contrast For Facial Nerve Evaluation; Functional MRI For Nerve Pathways
2) Computed Tomography (CT) Scan: CT Scan For Skull And Facial Bone Assessment; CT With Contrast For Detection Of Inflammation; High-Resolution CT For Nerve Damage Evaluation
3) By Electromyography (EMG): EMG For Facial Nerve Conduction; Nerve Conduction Velocity (NCV) Testing; EMG To Assess Severity Of Nerve Damage
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Bell's Palsy Treatment Market Characteristics
3. Bell's Palsy Treatment Market Trends And Strategies
4. Bell's Palsy Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Bell's Palsy Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Bell's Palsy Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bell's Palsy Treatment Market Growth Rate Analysis
5.4. Global Bell's Palsy Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bell's Palsy Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bell's Palsy Treatment Total Addressable Market (TAM)
6. Bell's Palsy Treatment Market Segmentation
6.1. Global Bell's Palsy Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT) Scan
Electromyography
6.2. Global Bell's Palsy Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Physical Therapy
Surgery
6.3. Global Bell's Palsy Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Specialty Clinics
6.4. Global Bell's Palsy Treatment Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Brain MRI To Rule Out Other Causes
MRI With Contrast For Facial Nerve Evaluation
Functional MRI For Nerve Pathways
6.5. Global Bell's Palsy Treatment Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CT Scan For Skull And Facial Bone Assessment
CT With Contrast For Detection Of Inflammation
High-Resolution CT For Nerve Damage Evaluation
6.6. Global Bell's Palsy Treatment Market, Sub-Segmentation Of Electromyography (EMG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
EMG For Facial Nerve Conduction
Nerve Conduction Velocity (NCV) Testing
EMG To Assess Severity Of Nerve Damage
7. Bell's Palsy Treatment Market Regional And Country Analysis
7.1. Global Bell's Palsy Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bell's Palsy Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
